21 research outputs found
CATALYTIC CRACKING OF TOLUENE USING RED MUD: HYDROGEN EVOLUTION AND CARBON FORMATION.
Toluene has been used as a model tar compound in many cracking and reforming studies in the context of biomass gasification and pyrolysis. Low cost alternate catalysts such as biochar, limonite have been studied. Toluene has also been used in chemical vapour deposition of carbon nano tubes. In this study, red mud waste from the aluminium industry without any pre treatment was used as a catalyst for toluene cracking. The hydrogen evolution and nano carbon formation were studied. The reduction behaviour of the catalyst in hydrogen showed conversion of iron hydroxide and oxide to iron above 700 ?C. Hydrogen formation rate was maximum at 800 ?C after around 7 h and subsequently reduced with time. Depending on the carbon content, the post reaction catalyst was comprised of reduced iron oxides (magnetite, wustite) and mixture of iron, iron carbide and graphitic carbon. Carbon content up to 46% was obtained and the deposited carbon was in the form of nano fibers. While red mud has been used in catalytic steam gasification and pyrolysis of biomass, the hydrogen evolution using red mud and toluene has not been reported
Multimedia e-learning on technologies for efficient water use
One of the Millennium Development Goals is “To ensure environmental sustainability”, with a special task dedicated to
halve by 2015 the proportion of people without sustainable access to safe drinking water. This task collides with alarming
studies that, for instance, foresee an acute water shortage in India and other Asian countries by 2050. In this conflicting
context we present ED-WAVE, a developing project funded by the Asia-Link Programme, participating six countries
(India, Sri Lanka, Thailand, Greece, Spain and Finland). Its goal is to create a sustainable international cooperation
framework and to develop a multimedia tool for e-Learning on technologies for conservation, reclamation and reuse of
natural resources. We therefore use IT tools aimed at improving people’s education, including analysis of current water
use status in Asia and Europe, review of potential technological interventions, simulation of impacts of specific technology
interventions and translation of knowledge into electronic teaching material
Improved reference genome of Aedes aegypti informs arbovirus vector control
Female Aedes aegypti mosquitoes infect more than 400 million people each year with dangerous viral pathogens including dengue, yellow fever, Zika and chikungunya. Progress in understanding the biology of mosquitoes and developing the tools to fight them has been slowed by the lack of a high-quality genome assembly. Here we combine diverse technologies to produce the markedly improved, fully re-annotated AaegL5 genome assembly, and demonstrate how it accelerates mosquito science. We anchored physical and cytogenetic maps, doubled the number of known chemosensory ionotropic receptors that guide mosquitoes to human hosts and egg-laying sites, provided further insight into the size and composition of the sex-determining M locus, and revealed copy-number variation among glutathione S-transferase genes that are important for insecticide resistance. Using high-resolution quantitative trait locus and population genomic analyses, we mapped new candidates for dengue vector competence and insecticide resistance. AaegL5 will catalyse new biological insights and intervention strategies to fight this deadly disease vector
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
To understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera (1–11 days post-admission) and 92 convalescent sera (56 with COVID-19-associated neurological diagnoses). Here we show that compared to 60 uninfected controls, tTau, GFAP, NfL, and UCH-L1 are increased with COVID-19 infection at acute timepoints and NfL and GFAP are significantly higher in participants with neurological complications. Inflammatory mediators (IL-6, IL-12p40, HGF, M-CSF, CCL2, and IL-1RA) are associated with both altered consciousness and markers of brain injury. Autoantibodies are more common in COVID-19 than controls and some (including against MYL7, UCH-L1, and GRIN3B) are more frequent with altered consciousness. Additionally, convalescent participants with neurological complications show elevated GFAP and NfL, unrelated to attenuated systemic inflammatory mediators and to autoantibody responses. Overall, neurological complications of COVID-19 are associated with evidence of neuroglial injury in both acute and late disease and these correlate with dysregulated innate and adaptive immune responses acutely
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed
Novel green bio-composite geopolymeric thermo-plasters for innovative building applications: upcycling spent coffee ground
This study proposes the reuse of spent coffee ground and biomass fly ash in the development of green geopolymeric thermo-plastering for innovative building applications. The former waste is the major residue of the brewing process, that is usually used as fertilisers or disposed of in landfill with extreme harmfulness for the natural environment. The latter is an industrial waste generated during the Kraft paper-pulp process, that is usually landfilled. The mortar is produced with a combination of metakaolin (30 wt.%) and biomass fly ash (70 wt.%), and natural siliceous sand filled with spent coffee ground (up to 17.5 wt.%). The high amount of reused waste makes the material an optimum candidate for the Environmental Minimum Criteria (CAM) assessment as ruled by the National Action Plan on Green Public Procurement. The overall manufacturing process occurred at ambient conditions (20 °C, 65% RH) contributing to the materials sustainability. 28-days cured specimens were analysed to assess the material engineering properties and delineate the possible applications in construction. Finally, virtual energy simulations were implemented to study the possible energetic performance benefits in a simplified building model. The major results are that the used wastes considerably improve the technological material performance making it suitable for effective use in construction. While the slurry workability is significantly affected by the waste introduction, and the mechanical resistance is still high, the thermal conductivity outlines a possible energy application. All considering, coffee waste can be effectively reused to manufacture green bio-composite materials with satisfactory performance considering the main requirements of a building making them exploitable in various applications in construction, especially in energy-saving functions, in line with the European directives towards zero-energy building
The coffee-house: Upcycling spent coffee grounds for the production of green geopolymeric architectural energy-saving products
This study investigates a possible alternative reuse of spent coffee grounds (SCG), the major residue of the brewing process, to manufacture green geopolymeric materials for innovative building applications in energy-saving construction, in line with the European Green Deal towards zero-energy building. Specimens were prepared by a combination of biomass fly ash from the Kraft paper-pulp process, as
raw material (70 wt%), and SCG (up to 17.5 %), as filler. The high amount of reused bio-wastes makes the material fit the requirements for the Minimum Environmental Criteria (MEC) certification, in light of the Circular Economy (CE) approach. Sustainability is also boosted by the manufacturing process that completely occurred at ambient conditions (20 C, 65 % RH). Materials engineering performance is evaluated to predict possible applications in construction and promote an integrated architectural design process to propose a ‘‘coffee-house” equipped with an innovative energy structure and envelope. For the scope, different technological solutions are designed and virtual energy modelling is implemented to simulate the performance of a building model in different climatic conditions and estimate the possible real efficacy of the proposed solutions in relation to building efficiency and cost management, as envisaged by the EU 2018/844 on the buildings’ energy performance. The major result is that the developed material represents an optimum candidate to substitute traditional construction and building materials with a great manufacturing financial saving, up to 37 % for the 17.5 % SCG, and an energy improvement up to about 19 % per year, leading further saving in the yearly building management